Trend

Testing demand

Dr Lal PathLabs CEO Om Manchanda sells stake as the stock gains over 50% over the past one year

Vishal Koul

The outbreak of coronavirus has fuelled a mini rally in pharma and healthcare stocks and Dr Lal PathLabs has been one of the beneficiaries of this surge. The diagnostic and healthcare service provider’s stock rose 5% to Rs.1,706 over the past one month. As the stock rallied, CEO Om Prakash Manchanda sold shares worth Rs.43.59 million on March 5, his second tranche in FY20 after he sold shares worth Rs.18 million in M

unsub

You don’t want to be left behind. Do you?

Our work is exclusively for discerning readers. To read our edgy stories and access our archives, you’ve to subscribe